I-MAK Defends ‘Patent Thicket’ Claims In Response To Thom Tillis Letter
The Organization Was Accused By The Senator Of Peddling Inaccuracies
I-MAK has defended its claims that patent thickets block generic and biosimilar market entry • Source: Mateusz Kubacki / Alamy Stock Photo 
